Novel advances in the regulation of signal transduction activity

Advances in Enzyme Regulation

Volumn 38, Issue 1, 1998, Pages 49-62

  Weber, George ^a   Shen, Fei ^a   Li, Wei ^a   Prajda, Noemi ^a,b   Hullan, Lehel ^b   Yang, Hongyuan ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

1-PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; GUANOSINE TRIPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL KINASE; PHOSPHOLIPASE C; PHOSPHOTRANSFERASE;

ANTINEOPLASTIC ACTIVITY; BREAST CARCINOMA; BREAST TUMOR; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RESEARCH; CELL CULTURE; CELL CYCLE; CELL DIVISION; CONFERENCE PAPER; DRUG EFFECT; ENZYME ACTIVITY; ENZYMOLOGY; HUMAN; HUMAN CELL; METABOLISM; OVARY CARCINOMA; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 4-KINASE; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; ENZYME INHIBITORS; GUANOSINE TRIPHOSPHATE; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE; PHOSPHOLIPASE C; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0031827774     PISSN: 00652571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0065-2571(98)00002-8     Document Type: Conference Paper

References (33)

1. G. WEBER, Biochemical strategy of cancer cells and the design of chemotherapy: G.H.A. Clowes Memorial Lecture, Cancer Res. 43, 3466-3492 (1983).
2. M. T. RIZZO and G. WEBER, 1-Phosphatidylinositol 4-kinase (EC 2.7.1.67): An enzyme linked with proliferation and malignancy, Cancer Res. 54, 2611-2614 (1994).
3. R. L. SINGHAL, N. PRAJDA, Y. A. YEH and G. WEBER, 1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): A proliferation- and malignancy-linked signal transduction enzyme, Cancer Res. 54, 5574-5578 (1994).
4. R. L. SINGHAL, Y. A. YEH, K. Y. LOOK, G. W. SLEDGE JR and G. WEBER, Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cells, Life Sci. 55, 1487-1492 (1994).
5. N. PRAJDA, R. L. SINGHAL, Y. A. YEH, E. OLAH, K. Y. LOOK and G. WEBER, Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetin, Life Sci. 56, 1587-1593 (1995).
6. R. L. SINGHAL, Y. A. YEH, N. PRAJDA, E. OLAH, G. W. SLEDGE JR and G. WEBER, Quercetin down-regulates signal transduction in human breast carcinoma cells, Biochem. Biophys. Res. Commun. 208, 425-431 (1995).
7. G. WEBER, R. L. SINGHAL, N. PRAJDA, Y. A. YEH, K. Y. LOOK and G. W. SLEDGE JR, Regulation of signal transduction, Advan. Enzyme Regul. 35, 1-21 (1995).
8. G. WEBER, F. SHEN, N. PRAJDA, H. YANG, W. LI, B. CSOKAY, E. OLAH and K. Y. LOOK, Regulation of the signal transduction program by drugs, Advan. Enzyme Regul. 37, 35-55 (1997).
9. G. WEBER, N. PRAJDA, H. YANG, Y. A. YEH, F. SHEN, R. L. SINGHAL, M. HERENYIOVA and K. Y. LOOK, Current issues in regulation of signal transduction, Advan. Enzyme Regul. 36, 33-55 (1996).
10. N. PRAJDA, E. OLAH, L. HULLAN, I. SZAMEL, O. CSUKA and Z. SULOK, Biochemical program of experimental and human breast tumors; effect of chemotherapy, Submitted for publication (1998).
11. G. J. TRICOT, H. N. JAYARAM, E. LAPIS, Y. NATSUMEDA, Y. YAMADA, C. R. NICHOLS, P. KNEEBONE, N. HEEREMA, G. WEBER and R. HOFFMAN, Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5′-phosphate dehydrogenase activity, Cancer Res. 49, 3696-3701 (1989).
12. G. TRICOT, H. N. JAYARAM, G. WEBER and R. HOFFMAN, Tiazofurin: biological effects and clinical uses, Intl. J. Cell Cloning 8, 161-170 (1990).
13. G. TRICOT and G. WEBER, Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with tiazofurin, a selective blocker of inosine 5′-monophosphate dehydrogenase (IMPDH) activity, Anticancer Res. 16, 3341-3348 (1996).
14. G. WEBER, N. PRAJDA, M. ABONYI, K. Y. LOOK and G. TRICOT, Tiazofurin: molecular and clinical action, Anticancer Res. 16, 3313-3322 (1996).
15. M. S. LUI, M. A. FADERAN, J. J. LIEPNICKS, Y. NATSUMEDA, E. OLAH, H. N. JAYARAM and G. WEBER, Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-β-D-ribofuranosylthiazole-4-carboximde), J. Biol. Chem. 259, 5078-5082 (1984).
16. G. WEBER and N. PRAJDA, Targeted and non-targeted actions of anti-cancer drugs, Advan. Enzyme Regul. 34, 71-89 (1994).
17. M. YOSHIDA, T. SAKAI, N. HOSOKAWA, N. MARUI, K. MATSUMOTO, A. KUJIOKA, H. NISHINO and A. AOIKE, The effect of quercetin on cell cycle progression and growth of human gastric cancer cells, FEBS Lett. 260, 10-13 (1990).
18. N. HOSOKAWA, Y. HOSOKAWA, T. SAKAI, M. YOSHIDA, N. MARUI, H. NISHINO, K. KAWAI and A. AOIKE, Inhibitory effect of quercetin on the synthesis of a possibly cell-cycle-related 17-KDA protein, in human colon cancer cells, Int. J. Cancer 45, 1119-1124 (1990).
19. 2-M, Cancer Res. 53, 1328-1331 (1993).
20. G. L. PAGLIACCI, F. SPINOZZI, G. MIGLIORATI, G. FUMI, M. SMACCHIA, F. RICCARDI and I. NICOLETTI, Genistein inhibits tumor cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a future pitfall in the use of the MTT assay for evaluating cell growth and survival, Eur. J. Cancer 29A, 1573-1577 (1993).
21. L. HUNAKOVA, J. SEDLAK, M. KLOBUSICKA, J. DURAJ and B. CHORVATH, Tyrosine kinase inhibitor-induced differentiation of K-562 cells: alterations of cell cycle and cell surface phenotype, Cancer Lett. 81, 81-87 (1994).
22. S. RAUTH, J. KICHINA and A. GREEN, Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by genistein: chemosensitivity is regulated by cellular p53, Brit. J. Cancer 75, 1559-1566 (1997).
23. H. NISHIOKA, M. IMOTO, T. SAWA, M. HAMADA, H. NAGANAWA, H. TAKEUCHI and K. UMEZAWA, Screening of phosphatidylinositol kinase inhibitors from streptomyces, J. Antibiotics 42, 823-825 (1989).
24. F. SHEN and G. WEBER, Synergistic action of quercetin and genistein in human ovarian carcinoma cells, Oncol. Res. (for publication), (1998Accepted).
25. S. L. PARKER, T. TONG, S. BOLDEN and P. A. WINGO, Cancer statistics, Cancer 46, 5-29 (1996).
26. K. Y. LOOK, D. H. MOORE, G. P. SUTTON, N. PRAJDA, M. ABONYI and G. WEBER, Increased thymidine kinase and thymidylate synthase activities in human epithelial ovarian carcinoma, Anticancer Res. 17, 2353-2356 (1997).
27. J. L. Webb, Enzyme and Metabolic Inhibitors. Acad. Press, New York. 1. pp. 507-510 (1963).
28. H. N. JAYARAM, R. L. DION, R. L. GLAZER, D. G. JOHNS, R. K. ROBINS, P. C. SRIVASTAVA and D. A. COONEY, Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-β-D-ribofuranosylthiazole-4-carboxamide (NSC 286193), Biochem. Pharmacol. 31, 2371-2380 (1982).
29. E. OLAH, B. CSOKAY, N. PRAJDA, Z. KOTE-ARAI, Y. A. YEH and G. WEBER, Molecular mechanisms in the antiproliferative action of taxol and tiazofurin, Anticancer Res. 16, 1-9 (1996).
30. B. CSOKAY, N. PRAJDA, G. WEBER and E. OLAH, Molecular mechanisms in the antiproliferative action of quercetin, Life Sci. 60, 2157-2163 (1997).
31. E. OLAH, Y. NATSUMEDA, T. IKEGAMI, Z. KOTE, M. HORANYI, J. SZELENYI, E. PAULIK, T. KREMMER, S. R. HOLLAN, J. SUGAR and G. WEBER, Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K562 leukemia cells, Proc. Natl. Acad. Sci. U.S.A. 85, 6533-6537 (1988).
32. A. CONSTANTINOU and E. HUBERMAN, Genistein as an inducer of tumor cell differentiation: possible mechanisms of action (43841), Proc. Soc. Exptl. Biol. Med. 208, 109-115 (1995).
33. W. LI and G. WEBER, Synergistic action of tiazofurin and genistein in human ovarian carcinoma cells, Submitted for publication (1998).